Biblio
Export 1237 results:
Author Title [ Type
Filters: First Letter Of Last Name is D [Clear All Filters]
“Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1283-1294, 2018.
, “Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.”, J Alzheimers Dis, vol. 97, no. 2, pp. 567-572, 2024.
, “Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 231-42, 2015.
, “Successful Object Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1195-1205, 2017.
, “Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1183-1202, 2021.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications.”, J Alzheimers Dis, vol. 60, no. 3, pp. 783-794, 2017.
, “A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1471-1481, 2018.
, “A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1471-1481, 2018.
, “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
, “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
, “A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1359-1379, 2017.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “TAR DNA-Binding Protein 43 Is Associated with Rate of Memory and Functional and Global Cognitive Decline in the Decade Prior to Death.”, J Alzheimers Dis, vol. 80, no. 2, pp. 683-693, 2021.
, “Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?”, J Alzheimers Dis, vol. 57, no. 2, pp. 493-504, 2017.
, “Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.”, J Alzheimers Dis, vol. 64, no. s1, pp. S427-S453, 2018.
, “Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.”, J Alzheimers Dis, vol. 64, no. s1, pp. S427-S453, 2018.
, “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
, “Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 4, pp. 965-75, 2015.
, “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
,